Demand of Pharyngitis Is Estimated to Surge More Than US$ 1.679 Billion By 2026 The global pharyngitis market is expected to witness sluggish growth. The market is likely to register a CAGR of 3.4% during the forecast period 2017–2026. The global pharyngitis market is also estimated to reach USD 1.679 billion by the end of 2026. Pharyngitis is the most common problem among people. Sore throats are mainly caused by the flu, colds or other diseases such as mononucleosis. Most health care providers diagnose pharyngitis with a rapid streptococcal test. Doctors give drugs only after determining whether the infection is viral or bacterial. Accordingly, drug manufacturers are conducting research to develop more effective pharyngitis treatments. Here are some insights on how the global pharyngitis market is likely to perform over the next few years. Download sample copy of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=361?AS 5 Forecast Highlights for the Global Sore throat Market 1- The Asia Pacific Excluding Japan (APEJ) is expected to maintain its dominant position in the global pharyngitis market during the forecast period. Group A streptococcal is the most common disease occurring in poor environments where poor living conditions allow the organism to be transmitted. APEJ thus provides an opportunity for pharmaceutical manufacturers. Additionally, the presence of major drug manufacturers in the region is also leading to the growth of the market. 2- North America is also expected to witness future growth. Smoking is very common among young adults and is significantly associated with sore throats. There has also been an increase in cases of acute pharyngitis diagnosed in children in the United States. 3- beta-lactam is expected to become one of the highly preferred class of drugs in the global pharyngitis market. By the end of 2026, sales of beta-lactams are estimated to approach US$500 million. 4- Retail Pharmacy and Pharmacy is projected to witness the highest growth during the forecast period 2017–2026. Retail pharmacies and drug stores are estimated to exceed USD 600 million in revenue by the end of 2026. 5- Oral drug delivery is expected to become the preferred route of drug administration because of its convenience and lowest cost. Oral drug delivery, accounting for more than half of revenue share, is estimated to exceed $1.2 billion in revenue by the end of 2026. competition tracking The report also introduces the companies expected to actively participate in the expansion of the global pharyngitis market by 2026. Pfizer GlaxoSmithKline PLC Novartis AG BioStar Pharmaceuticals Zambon Group SpA. drug type beta lactam macroride cephalosporin Fluoroquinolones tetracycline other products distribution channel hospital pharmacy Retail Pharmacy and Pharmacy online pharmacy delivery method oral- vein intramuscular Other delivery methods This report covers the following pharyngitis insights and assessments to help all participants involved in pharyngitis: Data on recently introduced regulations and their impact on key industries and demand for pharyngitis Up-to-date industrial pharyngitis with key analysis of market drivers, trends and influencing factors Analysis of key trends pharyngitis and changing consumer preferences in key industries. Changes in demand for pharyngitis and consumption of various products A major trend in funding by major investors from multiple countries New investment opportunities in a variety of technologies and types of products or services Comprehensive data and competitive analysis of major players in pharyngitis U.S. pharyngitis sales will grow at a steady rate, driven by growing consumer confidence and economic recovery.
Last changed by  
 
Factmrsurvey
15

Read more

Untitled

By the end of 2033, the chronic idiopathic constipation treatment market is expected to have grown from a projected value of US$ 9.4 billion in 2023 to US$ 19.7 billion, expanding quickly at a CAGR of 7.5%. When a person has difficult, infrequent, and/or suboptimal defecation, it is known as chronic idiopathic constipation (CIC), a common functional bowel disorder. Chronic idiopathic constipation is becoming more common due to factors like sedentary lifestyles, growing anti-inflammatory medicine use, and a rapid decline in dietary fibre consumption. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=8517 Additionally, rising rate of the ageing population, sedentary lifestyles, and dietary changes are contributing to the increasing burden of CIC, thereby driving the demand for treatment options. Fiber supplements, laxatives, stool softeners, and prokinetic agents are commonly used as medications in the management of CIC. Furthermore, advancements in digital health technologies are also shaping the future of chronic idiopathic constipation treatment. Mobile applications, wearable devices, and remote monitoring tools are being developed to help patients track their bowel movements, diet, and exercise habits, and provide personalized recommendations for managing CIC.

8/7/2023
Untitled

The Automotive Ceramics Industry sales study offers a comprehensive analysis on diverse features including production capacities, Automotive Ceramics demand, product developments, sales revenue generation and Automotive Ceramics market outlook across the globe. 170 page market research report by Fact.MR, (Leading business and competitive intelligence provider) on global Automotive Ceramics market sales initiates with an outlook of the market, followed by the scrutiny of the demand and consumption volumes and share and size of various end-use segments The global automotive ceramics market was valued at US$ 2.3 Billion in 2021 and market is valued at US$ 2.42 Billion in 2022 During the 2022-2032 period of assessment, demand is expected to rise at a 5.4% value CAGR, likely to reach US$ 6.6 Billion by the end of the said forecast period. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=6406 The readability score of the Automotive Ceramics market demand report is good as it offers chapter-wise layout with each section divided into a smaller sections.

8/7/2023
Preimplantation Genetic Testing Market to Hit Valuation of US$ 1,420 Million by 2032

Through 2032, the preimplantation genetic testing market is anticipated to develop at a CAGR of around 9% and reach a significant market size. Growth opportunities are expanding as a result of the rising prevalence of genetic illnesses. The market is anticipated to reach US$ 653.52 million by 2022 and will continue to grow, reaching US$ 1,420 million by 2032. Download Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=292 The biggest benefit offered by preimplantation testing is it offers an opportunity to conceive a pregnancy unaffected by genetic conditions. Researchers and healthcare institutes are trying to find new methods and techniques using the latest technology to minimize various risks associated with preimplantation genetic testing. Key Highlights

8/7/2023
Global Implantable Medical Devices Market Is Predicted To Reach US$ 155 Billion By 2027

According to Fact.MR’s most recent industry analysis, implanted medical device market sales are expected to grow globally between 2022 and 2027 at a compound annual growth rate of 6.1%. The market for implantable medical devices is expanding as a result of increased chronic illness prevalence, an ageing population, and improvements in active implanted medical devices. Additionally, increased funding and investments in the creation of technologically advanced products, elevated awareness of advancements in medical implants, and an increase in the use of neurostimulators are all contributing to market expansion. Download Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7728 Incidence of cardiovascular diseases is rising, and obesity rates are high, which are the main drivers that are likely to fuel market growth for implantable medical devices. Medical professionals and patients can monitor their illnesses to receive an early update with the use of implantable medical devices. These wireless, automated devices assess a patient’s sensitivity to a prescribed medicine dosage. The rising prevalence of neurological illnesses such as Parkinson’s disease and spasticity is driving the demand for active implantable medical devices.

8/7/2023
Read more from Factmrsurvey
Published on HackMD